ArticleMolecular biology reports2025
Improving directed evolution strategies: error-prone PCR optimization for SARS-CoV-2 spike receptor binding domain.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman coronaviruses are pathogenic viruses that have the ability to cause serious diseases or even death in humans. The receptor binding domain (RBD) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the region of the spike protein, through which the virus directly interacts with the human Angiotensin-converting enzyme 2 receptor (ACE-2). Understanding the mutations that occur in the RBD and determining their influence on host cell binding plays an essential role in learning about the transmission mechanism of the disease and developing potential treatment.
methodsWe chose to apply the error-prone Polymerase Chain Reaction (ep-PCR), usually used in directed evolution and targeted mutagenesis applications, and to optimize it for the SARS-CoV-2 RBD sequence. This was followed by sequencing to analyze the mutation pattern. In this study, a novel ep-PCR protocol was developed specifically for RBD, optimized for dNTP ratios, magnesium ions, manganese ions, and cycle numbers.
resultsDistribution of mutations in the RBD sequence was determined. The effect of each parameter on the generation of mutations showed that MnCl
conclusionOur results highlight the virulence-enhancing potential of mutations and enable researchers to evaluate potential vaccine candidates in the future. Furthermore, compared to earlier reports, the method described here requires only Sanger sequencing and a standard PCR cycler, therefore it is much more accessible. Most importantly, it yields combinatorial mutation diversity in one round, along the entire length of the sequence of interest.
Indexed as
Identifiers
41369845What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.